
NuVasive NUVA
Quarterly report 2023-Q2
added 08-02-2023
NuVasive Interest Expense 2011-2026 | NUVA
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.4 M | -25.5 M | -16.9 M | -5.92 M | -8.17 M | -1.54 M | -305 K | 425 K | -2.41 M | 3.1 M | 1.05 M | 2.08 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.1 M | -25.5 M | -6.29 M |
Quarterly Interest Expense NuVasive
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -826 K | -4.44 M | - | -21.1 M | -29.7 M | 16.2 M | - | -13.1 M | 1.27 M | -12.5 M | - | 251 K | -11.7 M | -7.41 M | - | -5.7 M | 9 K | -366 K | - | 4.24 M | -2.38 M | -9.7 M | - | -139 K | -501 K | 258 K | - | 94 K | -246 K | 50 K | - | 387 K | -281 K | 424 K | - | -2.49 M | -205 K | 375 K | - | 3.14 M | -440 K | 240 K | - | 260 K | -551 K | 437 K | - | 1.73 M | 80 K | 497 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.2 M | -29.7 M | -2.47 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 7.75 | 10.87 % | $ 1.16 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.16 | 15.72 % | $ 156 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.15 | -3.15 % | $ 1.31 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.57 | 2.63 % | $ 412 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.23 | -2.88 % | $ 62.5 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.68 | 1.83 % | $ 331 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 70.93 | 7.04 % | $ 3.87 B | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 12.07 | -0.98 % | $ 478 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 11.24 | -0.18 % | $ 403 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
-668 K | $ 0.87 | 2.18 % | $ 36.4 M | ||
|
Electromed
ELMD
|
78 K | $ 26.86 | 3.55 % | $ 227 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 160.4 | 6.03 % | $ 11.3 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.24 | -6.71 % | $ 898 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.39 | -0.42 % | $ 6.63 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 85.07 | -4.65 % | $ 11.5 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 38.1 | 2.09 % | $ 1.18 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 45.57 | -0.28 % | $ 1.34 B | ||
|
Tandem Diabetes Care
TNDM
|
-13 M | $ 18.47 | 2.44 % | $ 1.26 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 87.92 | 1.89 % | $ 3.05 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 82.76 | -0.53 % | $ 48.4 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 72.9 | -0.03 % | $ 2.48 B |